Mark Hollywood

Insider Reports History

Location
Vancouver
Signature
/s/ Daniel Dex, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Hollywood:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zymeworks Inc. EVP & Chief Operating Officer Common Stock 132,913 $3,013,602 $22.67 12 Jan 2026 Direct
Zymeworks Inc. EVP & Chief Operating Officer Stock Option (Right to Buy) 70,000 12 Jan 2026 Direct
Zymeworks Inc. EVP & Chief Operating Officer Performance Stock Unit 66,000 12 Jan 2026 Direct
Zymeworks Inc. EVP & Chief Operating Officer Restricted Stock Unit 47,000 12 Jan 2026 Direct

Insider Reports Filed by Mark Hollywood

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ZYME Zymeworks Inc. 12 Jan 2026 6 -$138,762 4 EVP & Chief Operating Officer 13 Jan 2026, 17:11
ZYME Zymeworks Inc. 09 Jan 2026 0 $0 3 EVP & Chief Operating Officer 13 Jan 2026, 17:04